Dramatic elevations of interleukin-6 and acute-phase reactants in athletes participating in the ultradistance foot race Spartathlon: Severe systemic inflammation and lipid and lipoprotein changes in protracted exercise

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 7, 2005, Pages 3914-3918

  Margeli, Alexandra ^a   Skenderi, Katerina ^b   Tsironi, Maria ^c   Hantzi, Eugenia ^a   Matalas, Antonia Leda ^b   Vrettou, Christina ^d   Kanavakis, Emmanuel ^d   Chrousos, George ^e   Papassotiriou, Ioannis ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b HAROKOPIO UNIVERSITY   (Greece)

^c Department of Internal Medicine   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERUM AMYLOID A; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHLETE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; EXERCISE; HUMAN; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; SPORT; STATISTICAL SIGNIFICANCE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME;

ACUTE-PHASE PROTEINS; ADULT; C-REACTIVE PROTEIN; DNA; EXERCISE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; RUNNING; SERUM AMYLOID A PROTEIN;

EID: 23044475503     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-2346     Document Type: Article

References (44)

1. Pedersen BK 2000 Special feature: exercise and cytokines. Immunol Cell Biol 78:532-535
2. Cannon JG, Kluger MJ 1983 Endogenous pyrogen activity in human plasma after exercise. Science 220:617-619
3. Ostrowski K, Rohde T, Zacho M, Asp S, Pedersen BK 1998 Evidence that IL-6 is produced in skeletal muscle during intense long-term muscle activity. J Physiol (Lond) 508:949-953
4. Fallon KE 2001 The acute phase response and exercise: the ultramarathon as prototype exercise. Clin J Sport Med 11:38-43
5. Pyne DB 1994 Exercise-induced muscle damage and inflammation: a review. Aust J Sci Med Sport 26:49-58
6. Papanicolaou DA, Petrides JS, Tsigos C, Bina S, Kalogeras KT, Wilder R, Gold PW, Deuster PA, Chrousos GP 1996 Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol 271:E601-E605
7. Singh A, Papanicolaou DA, Lawrence LL, Howell EA, Chrousos GP, Deuster PA 1999 Neuroendocrine responses to exhaustive running in women. Med Sci Sports Exerc 31:536-542
8. Abramson JL, Vaccarino V 2002 Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med 162:1286-1292
9. Gabay C, Kushner I 1999 Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448-454
10. Hardardottir I, Grunfeld C, Feingold KR 1994 Effects of endotoxin and cytokines on lipid metabolism. Curr Opin Lipidol 5:207-215
11. Khovidhunkit W, Memon RA, Feingold KR, Grunfeld C 2000 Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis 181(Suppl 3):S462-S472
12. Smith GD, Shipley MJ, Batty GD, Morris JN, Marmot M 2000 Physical activity and cause-specific mortality in the Whitehall Study. Public Health 114:308-315
13. Sesso HD, Paffenbarger Jr RS, Lee IM 2000 Physical activity and coronary heart disease in men: the Harvard Alumni Health Study. Circulation 102:975-980
14. Haapanen N, Miilunpalo S, Vuori I, Oja P, Pasanen M 1997 Association of leisure time physical activity with the risk of coronary heart disease, hypertension and diabetes in middle-aged men and women. Int J Epidemiol 26:739-747
15. Lee IM, Rexrode KM, Cook NR, Manson JE, Buring JE 2001 Physical activity and coronary heart disease in women: is "no pain, no gain" passe? JAMA 285:1447-1454
16. Weissberg PL, Bennett MR 1999 Atherosclerosis: an inflammatory disease. N Engl J Med 340:1928-1929
17. Williams PT 1996 High-density lipoprotein cholesterol and other risk factors for coronary heart disease in female runners. N Engl J Med 334:1298-1303
18. Van Lenten BJ, Hama SY, de Beer FC, Stafforini DM, McIntyre TM, Prescott SM, LaDu BN, Fogelman AM, Navab M 1995 Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 96:2758-2767
19. Van Lenten BJ, Wagner AC, Anantharamaiah GM, Garber DW, Fishbein MC, Adhikary L, Nayak DP, Hama S, Navab M, Fogelman AM 2002 Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide. Circulation 106:1127-1132
20. Northoff H, Berg A 1991 Immunologic mediators as parameters of the reaction to strenuous exercise. Int J Sports Med 12:S9-S15
21. Ullum H, Haahr PM, Diamant M, Palmo J, Halkjaer-Kristensen J, Pedersen BK 1994 Bicycle exercise enhances plasma IL-6 but does not change IL-1α, IL-1β, IL-6, or TNF-α pre-mRNA in BMNC. J Appl Physiol 77:93-97
22. Drenth JPH, Krebbers RJM, Bijzet J, van der Meer JWM 1998 Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1β production but decreased tumour necrosis factor-α production after a 5-km run. Eur J Clin Invest 28:866-872
23. Drenth JPH, Van Uum SHM, Van Deuren M, Pesman GJ, Van der Ven-Jongekrijg J, Van der Meer JWM 1995 Endurance run increases circulating IL-6 and IL-1rα but downregulates ex vivo TNF-α and IL-1β production. J Appl Physiol 79:1497-1503
24. Dufeaux B, Order U 1989 Plasma elastase-α1-antitrypsin, neopterin, tumor necrosis factor, and soluble interleukin-2 receptor after prolonged exercise. Int J Sports Med 10:434-438
25. Ceciliani F, Giordano A, Spagnolo V 2002 The systemic reaction during inflammation: the acute-phase proteins. Protein Pept Lett 9:211-223
26. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP 1998 The pathophysiologic roles of interleukin-6 in humans. Ann Intern Med 128:127-137
27. Tsigos C, Papanicolaou DA, Defensor R, Mitsiades CS, Kyrou I, Chrousos GP 1997 Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology 66:54-62
28. Tsigos C, Papanicolaou DA, Kyrou I, Defensor R, Mitsiadis CS, Chrousos GP 1997 Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 82:4167-4170
29. Meduri GU, Tolley EA, Chrousos GP and Stentz F 2002 Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving ARDS: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med 165:983-991
30. Chrousos GP 2000 Stress, chronic inflammation, and emotional and physical well-being: concurrent effects and chronic sequelae. J Allergy Clin Immunol 106:S275-S291
31. Lycopoulou L, Mamoulakis C, Hantzi E, Demetriadis D, Antypas S, Giannaki M, Bakoula C, Chrousos G, Papassotiriou I 2005 Serum amyloid A protein levels as a possible aid in the diagnosis of acute appendicitis in children. Clin Chem Lab Med 43:49-53
32. Pizzini C, Mussap M, Plebani M, Fanos V 2000 C-reactive protein and serum amyloid A protein in neonatal infections. Scand J Infect Dis 32:229-235
33. Suffredini AF, Fantuzzi G, Badolato R, Oppenheim JJ, O'Grady NP 1999 New insights into the biology of the acute phase response. J Clin Immunol 19:203-214
34. Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK 1999 Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 515:287-291
35. Castell LM, Poormans JR, Leclercq R, Brasseur M, Duchateau J, Newsholme EA 1997 Some aspects of the acute phase response after a marathon race, and the effects of glutamine supplementation. Eur J Appl Physiol 75:47-53
36. Hardardottir I, Moser AH, Memon R, Grunfeld C, Feingold KR 1994 Effects of TNF, IL-1, and the combination of both cytokines on cholesterol metabolism in Syrian hamsters. Lymphokine Cytokine Res 13:161-166
37. Salazar A, Pinto X, Mana J 2001 Serum amyloid A and high-density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders. Eur J Clin Invest 31:1070-1077
38. Kisilevsky R, Tam SP 2002 Acute phase serum amyloid A, cholesterol metabolism, and cardiovascular disease. Pediatr Pathol Mol Med 21:291-305
39. Sammalkorpi K, Valtonen V, Kerttula Y, Nikkila E, Taskinen MR 1988 Changes in serum lipoprotein pattern induced by acute infections. Metabolism 37:859-865
40. Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR 1992 Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 74:1045-1052
41. Cabana VG, Lukens JR, Rice KS, Hawkins TJ, Getz GS 1996 HDL content and composition in acute phase response in three species. J Lipid Res 37:2662-2674
42. Van Lenten BJ, Navab M, Shih D, Fogelman AM, Lusis AJ 2001 The role of high-density lipoproteins in oxidation and inflammation. Trends Cardiovasc Med 11:155-161
43. Navab M, Berliner JA, Subbanagounder G, Hama S, Lusis AJ, Castellani LW, Reddy S, Shih D, Shi W, Watson AD, Van Lenten BJ, Vora D, Fogelman AM 2001 HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol 21:481-488
44. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, Bales CW, Henes S, Samsa GP, Otvos JD, Kulkarni KR, Slentz CA 2002 Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 347:1483-1492